Orally administering parathyroid hormone and calcitonin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/29 (2006.01) A61K 38/23 (2006.01) A61K 47/18 (2006.01)

Patent

CA 2446929

A method for orally administering a parathyroid hormone, PTH, comprising orally co-administering to a patient in need of PTH an effective amount of a PTH and an effective amount of a calcitonin. The method according to the invention allows for the oral administration of PTH without the hypercalcemia, hypercalcuria and nephrolithiasis side effects.

Cette invention concerne une méthode d'administration orale d'une hormone parathyroïde (PTH), consistant à co-administrer par voie orale à un patient ayant besoin de PTH une quantité efficace de PTH ainsi qu'une quantité efficace d'une calcitonine. Selon cette invention, cette méthode permet l'administration orale de PTH sans l'apparition des effets secondaires de l'hypercalcémie, l'hypercalciurie et de la lithiase rénale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Orally administering parathyroid hormone and calcitonin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally administering parathyroid hormone and calcitonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally administering parathyroid hormone and calcitonin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1833042

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.